Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Medical oncology · Renji Hospital · Shanghai

Dr. Shi Yaoping史瑶平

Associate Chief Physician
Deputy department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Shi Yaoping

Professional overview

Associate Chief Physician in the Department of Interventional Oncology at Renji Hospital (East Campus), specializing in image-guided minimally invasive interventions for solid tumors and benign conditions.

SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentDepartment of Interventional Oncology
HospitalRenji Hospital
CityShanghai
Hospital roleDeputy Director, Department of Interventional Oncology
CampusEast Campus

Department leadership

Deputy department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

Interventional oncologyComprehensive interventional treatment of malignant solid tumors including hepatocellular carcinoma, lung cancer, and renal cell carcinoma, using ablation, transarterial chemoembolization, and radioactive seed implantation.
Image-guided ablationDiagnosis and minimally invasive ablation therapy for pulmonary nodules and thyroid nodules.
Embolization therapyInterventional embolization for benign conditions including hepatic hemangioma, splenomegaly/hypersplenism, uterine fibroids/adenomyosis, renal angiomyolipoma, and benign prostatic hyperplasia.
Percutaneous drainage and sclerotherapyPercutaneous transhepatic cholangial drainage (PTCD) and sclerotherapy for hepatic and renal cysts.
Embolization for hemorrhageInterventional embolization for various bleeding conditions including hemoptysis, gastrointestinal bleeding, and renal hemorrhage.
Image-guided biopsyUltrasound- and CT-guided percutaneous biopsy for various diseases.

Background

  • 2014Recipient of the Trainee Research Prize at the Radiological Society of North America (RSNA) Annual Meeting
  • 2024Recipient of the 2024 Interventional Rising Star Award at the Chinese College of Interventional Radiology Annual Meeting (CCI)

Experience & recognition

  • First-author (including co-first-author) publications in Nature, Signal Transduction and Targeted Therapy (STTT), Radiology, Clinical Cancer Research, and Cancer Communication
  • 15 first-author (including co-first-author) SCI publications and 5 core Chinese journal publications
  • Principal investigator of 1 National Natural Science Foundation of China (NSFC) project, 1 Shanghai Natural Science Foundation project, and 1 Society of Interventional Radiology (SIR) project
  • Principal investigator of 2 Renji Hospital Clinical Research Innovation Incubation Fund projects
  • Contributor to multiple projects funded by the Ministry of Science and Technology (MOST), National Natural Science Foundation of China (NSFC), and Shanghai Municipal Science and Technology Commission

Professional roles

  • Member, Interventional Oncology Professional Committee, China Anti-Cancer Association (CACA)
  • Member, Minimally Invasive Treatment Professional Committee, China Anti-Cancer Association (CACA)
  • Member, Youth Expert Working Group, Chinese Medical Doctor Association (CMDA) Interventional Physicians Branch
  • Standing Committee Member, Minimally Invasive Treatment Professional Committee, Shanghai Anti-Cancer Association
  • Member, Ablation Therapy Professional Committee, Shanghai Anti-Cancer Association
  • Deputy Leader, Youth Committee, Interventional Oncology Specialty Branch, Shanghai Medical Association
  • Member, Interventional Diagnosis and Treatment Expert Committee, Bethune Public Welfare Foundation

Frequently asked questions

What does Dr. Shi Yaoping specialize in?

Specializes in comprehensive interventional treatment of malignant solid tumors (e.g., liver cancer, lung cancer, kidney cancer) using ablation, transarterial chemoembolization, and radioactive seed implantation; diagnosis and ablation of pulmonary and thyroid nodules; embolization for benign conditions including hepatic hemangioma, splenomegaly, uterine fibroids, renal angiomyolipoma, and benign prostatic hyperplasia; PTCD and cyst sclerotherapy; embolization for hemoptysis, gastrointestinal bleeding, and renal hemorrhage; and ultrasound/CT-guided biopsy.

Which hospital and department is Dr. Shi Yaoping in?

Department of Interventional Oncology at Renji Hospital (East Campus)

Sources

Dr. Shi Yaoping has not reviewed this page. Request a correction or removal.